Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

[ESCULAPIO: A project to elaborate strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population].

Bechini A, Bonanni P, Moscadelli A, Lauri S, Tiscione E, Levi M, Prato R, Fortunato F, Martinelli D, Gasparini R, Panatto D, Amicizia D, Coppola RC, Pellizzari B, Tabacchi G, Costantino C, Casuccio A, Vitale F, Iannazzo S, Boccalini S.

Epidemiol Prev. 2019 Jan-Feb;43(1):71-75. doi: 10.19191/EP19.1.P71.023. Italian.

2.

Analysis of influenza vaccination coverage among the elderly in Genoa (Italy) based on a deprivation index, 2009-2013.

Vercelli M, Lillini R, Arata L, Zangrillo F, Bagnasco A, Sasso L, Magliani A, Gasparini R, Amicizia D, Panatto D.

J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E11-E17. doi: 10.15167/2421-4248/jpmh2018.59.4s2.1171. eCollection 2018 Dec.

3.

Influenza vaccination coverage in the elderly and socio-economic inequalities in Italy.

Panatto D, Gasparini R, Amicizia D.

J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E1-E2. doi: 10.15167/2421-4248/jpmh2018.59.4s2.1198. eCollection 2018 Dec. No abstract available.

4.

Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment.

de Waure C, Boccalini S, Bonanni P, Amicizia D, Poscia A, Bechini A, Barbieri M, Capri S, Specchia ML, Di Pietro ML, Arata L, Cacciatore P, Panatto D, Gasparini R.

Eur J Public Health. 2019 Mar 30. pii: ckz041. doi: 10.1093/eurpub/ckz041. [Epub ahead of print]

PMID:
30929026
5.

Inflammatory bowel disease epidemiology in São Paulo State, Brazil.

Gasparini RG, Sassaki LY, Saad-Hossne R.

Clin Exp Gastroenterol. 2018 Oct 30;11:423-429. doi: 10.2147/CEG.S176583. eCollection 2018.

6.

Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.

Oltra-Cucarella J, Ferrer-Cascales R, Alegret M, Gasparini R, Díaz-Ortiz LM, Ríos R, Martínez-Nogueras ÁL, Onandia I, Pérez-Vicente JA, Cabello-Rodríguez L, Sánchez-SanSegundo M.

Psychol Aging. 2018 Nov;33(7):1007-1021. doi: 10.1037/pag0000294. Epub 2018 Oct 4.

PMID:
30284855
7.

Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387].

Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, Pazdiora P, Plesca D, Desole MG, Kevalas R, Gabutti G, Povey M, Innis B.

Vaccine. 2018 Oct 29;36(45):6894. doi: 10.1016/j.vaccine.2018.09.022. Epub 2018 Sep 21. No abstract available.

8.

Influenza vaccination of elderly: relaunch time.

Amicizia D, Lai PL, Gasparini R, Panatto D.

Ann Ig. 2018 Jul-Aug;30(4 Supple 1):16-22. doi: 10.7416/ai.2018.2229.

9.

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification.

Agersborg S, Mixon C, Nguyen T, Aithal S, Sudarsanam S, Blocker F, Weiss L, Gasparini R, Jiang S, Chen W, Hess G, Albitar M.

Breast Cancer Res Treat. 2018 Jul;170(2):321-328. doi: 10.1007/s10549-018-4755-5. Epub 2018 Mar 22.

10.

Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis.

Panatto D, Signori A, Lai PL, Gasparini R, Amicizia D.

Influenza Other Respir Viruses. 2018 Jul;12(4):533-543. doi: 10.1111/irv.12550. Epub 2018 Mar 23.

11.

[The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports].

Di Nardo F, Boccalini S, Calabrò GE, Marcellusi A, Ruggeri M, Bonanni P, Vitali R, Capannini E, Mennini FS, Cicchetti A, Panatto D, Gasparini R, Ricciardi W, De Waure C.

Ig Sanita Pubbl. 2017 Sep-Oct;73(5):453-471. Italian.

PMID:
29433132
12.

Associations between inflammatory bowel diseases and vitamin D.

Barbalho SM, Goulart RA, Gasparini RG.

Crit Rev Food Sci Nutr. 2019;59(8):1347-1356. doi: 10.1080/10408398.2017.1406333. Epub 2017 Dec 13.

PMID:
29236523
13.

One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.

Henry O, Brzostek J, Czajka H, Leviniene G, Reshetko O, Gasparini R, Pazdiora P, Plesca D, Desole MG, Kevalas R, Gabutti G, Povey M, Innis B.

Vaccine. 2018 Jan 8;36(3):381-387. doi: 10.1016/j.vaccine.2017.11.081. Epub 2017 Dec 7. Erratum in: Vaccine. 2018 Oct 29;36(45):6894.

14.

A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation.

Panatto D, Amicizia D, Arata L, Lai PL, Gasparini R.

Hum Vaccin Immunother. 2018 Apr 3;14(4):969-977. doi: 10.1080/21645515.2017.1407483. Epub 2018 Jan 3.

15.

Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014.

Marchi S, Trombetta CM, Gasparini R, Temperton N, Montomoli E.

J Prev Med Hyg. 2017 Mar;58(1):E27-E33.

16.

Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®).

Amicizia D, Arata L, Zangrillo F, Panatto D, Gasparini R.

J Prev Med Hyg. 2017 Mar;58(1):E1-E8. Review.

17.

The role of age-sex interaction in the development of post-herpetic neuralgia.

Amicizia D, Domnich A, Arata L, Zoli D, Zotti CM, Cacello E, Gualano MR, Gasparini R, Panatto D.

Hum Vaccin Immunother. 2017 Feb;13(2):376-378. doi: 10.1080/21645515.2017.1264799.

18.

Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project.

Bechini A, Bonanni P, Lauri S, Tiscione E, Levi M, Prato R, Fortunato F, Martinelli D, Gasparini R, Panatto D, Amicizia D, Coppola RC, Pellizzari B, Tabacchi G, Costantino C, Vitale F, Iannazzo S, Boccalini S.

Hum Vaccin Immunother. 2017 Feb;13(2):369-375. doi: 10.1080/21645515.2017.1268008.

19.

Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.

Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D.

Vaccine. 2017 Jan 23;35(4):513-520. doi: 10.1016/j.vaccine.2016.12.011. Epub 2016 Dec 23. Review.

20.

Knowledge, attitudes and behaviors of the Italian population towards Neisseria meningitidis, Streptococcus pneumoniae and HPV diseases and vaccinations: A cross-sectional multicentre study.

de Waure C, Quaranta G, Ianuale C, Panatto D, Amicizia D, Apprato L, Campanella P, Colotto M, De Meo C, Di Nardo F, Frisicale EM, La Milia DI, Rizzitelli E, Aquilani S, Briata MP, Frumento V, Marensi L, Spadea A, Turello V, Gasparini R, Ricciardi W.

Public Health. 2016 Dec;141:136-142. doi: 10.1016/j.puhe.2016.09.006. Epub 2016 Oct 14.

PMID:
27931989
21.

Economic studies applied to vaccines against invasive diseases: An updated budget impact analysis of age-based pneumococcal vaccination strategies in the elderly in Italy.

Boccalini S, Bechini A, Gasparini R, Panatto D, Amicizia D, Bonanni P.

Hum Vaccin Immunother. 2017 Feb;13(2):417-422. doi: 10.1080/21645515.2017.1264827. Epub 2016 Dec 7.

22.

An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign.

Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Carozzo S, Signori A, Bechini A, Boccalini S.

J Med Internet Res. 2016 Dec 2;18(12):e316.

23.

Clustering of health-related behaviors among early and mid-adolescents in Tuscany: results from a representative cross-sectional study.

Lazzeri G, Panatto D, Domnich A, Arata L, Pammolli A, Simi R, Giacchi MV, Amicizia D, Gasparini R.

J Public Health (Oxf). 2018 Mar 1;40(1):e25-e33. doi: 10.1093/pubmed/fdw134.

24.

Assessing spatial inequalities in accessing community pharmacies: a mixed geographically weighted approach.

Domnich A, Arata L, Amicizia D, Signori A, Gasparini R, Panatto D.

Geospat Health. 2016 Nov 16;11(3):457. doi: 10.4081/gh.2016.457.

25.

Facing Terminal Ileitis: Going Beyond Crohn's Disease.

Goulart RA, Barbalho SM, Gasparini RG, de Carvalho AC.

Gastroenterology Res. 2016 Feb;9(1):1-9. Epub 2016 Mar 8. Review.

26.

Reflections About Inflammatory Bowel Disease and Vitamins A and D.

Barbalho SM, Bechara MD, de Alvares Goulart R, Quesada K, Gasparini RG, de Cássio Alves de Carvalho A, Fiorini AM.

J Med Food. 2016 Dec;19(12):1105-1110. Epub 2016 Oct 25. Review.

PMID:
27779898
27.

Development and validation of the Italian version of the Mobile Application Rating Scale and its generalisability to apps targeting primary prevention.

Domnich A, Arata L, Amicizia D, Signori A, Patrick B, Stoyanov S, Hides L, Gasparini R, Panatto D.

BMC Med Inform Decis Mak. 2016 Jul 7;16:83. doi: 10.1186/s12911-016-0323-2.

28.
29.

Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Bragazzi NL, Orsi A, Ansaldi F, Gasparini R, Icardi G.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2616-2627. doi: 10.1080/21645515.2016.1187343. Epub 2016 May 31. Review.

30.

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis.

Gasparini R, Landa P, Amicizia D, Icardi G, Ricciardi W, de Waure C, Tanfani E, Bonanni P, Lucioni C, Testi A, Panatto D.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2148-2161. Epub 2016 May 10.

31.

Impact of different scoring algorithms applied to multiple-mark survey items on outcome assessment: an in-field study on health-related knowledge.

Domnich A, Panatto D, Arata L, Bevilacqua I, Apprato L, Gasparini R, Amicizia D.

J Prev Med Hyg. 2015;56(4):E162-71.

32.

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.

Gasparini R, Mennini FS, Panatto D, Bonanni P, Bechini A, Ricciardi W, DE Waure C, Marcellusi A, Cicchetti A, Ruggeri M, Boccalini S.

J Prev Med Hyg. 2015;56(4):E150-4.

33.

Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention.

Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Bragazzi NL, Signori A, Landa P, Bechini A, Boccalini S.

Hum Vaccin Immunother. 2016 Apr 2;12(4):1080-4. doi: 10.1080/21645515.2015.1114196. Epub 2016 Jan 21.

34.

The "urban myth" of the association between neurological disorders and vaccinations.

Gasparini R, Panatto D, Lai PL, Amicizia D.

J Prev Med Hyg. 2015 Jun 10;56(1):E1-8.

35.

Meningococcal B vaccination strategies and their practical application in Italy.

Gasparini R, Amicizia D, Lai PL, Panatto D.

J Prev Med Hyg. 2015 Aug 31;56(3):E133-9. Review.

36.

Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes.

Alicino C, Bragazzi NL, Faccio V, Amicizia D, Panatto D, Gasparini R, Icardi G, Orsi A.

Infect Dis Poverty. 2015 Dec 10;4:54. doi: 10.1186/s40249-015-0090-9.

37.

Human Papillomavirus Vaccine: State of the Art and Future Perspectives.

Panatto D, Amicizia D, Bragazzi NL, Rizzitelli E, Tramalloni D, Valle I, Gasparini R.

Adv Protein Chem Struct Biol. 2015;101:231-322. doi: 10.1016/bs.apcsb.2015.08.004. Epub 2015 Nov 11. Review.

PMID:
26572981
38.

Porous Alumina as a Promising Biomaterial for Public Health.

Bragazzi NL, Gasparini R, Amicizia D, Panatto D, Larosa C.

Adv Protein Chem Struct Biol. 2015;101:213-29. doi: 10.1016/bs.apcsb.2015.08.003. Epub 2015 Sep 26. Review.

PMID:
26572980
39.

Quartz-Crystal Microbalance (QCM) for Public Health: An Overview of Its Applications.

Bragazzi NL, Amicizia D, Panatto D, Tramalloni D, Valle I, Gasparini R.

Adv Protein Chem Struct Biol. 2015;101:149-211. doi: 10.1016/bs.apcsb.2015.08.002. Epub 2015 Sep 26. Review.

PMID:
26572979
40.

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines After Coadministration.

Gasparini R, Tregnaghi M, Keshavan P, Ypma E, Han L, Smolenov I.

Pediatr Infect Dis J. 2016 Jan;35(1):81-93. doi: 10.1097/INF.0000000000000930.

PMID:
26398743
41.

Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes.

Domnich A, Gasparini R, Amicizia D, Boccadifuoco G, Giuliani MM, Panatto D.

J Immunol Res. 2015;2015:353461. doi: 10.1155/2015/353461. Epub 2015 Aug 17. Review.

42.

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Gasparini R, Panatto D, Bragazzi NL, Lai PL, Bechini A, Levi M, Durando P, Amicizia D.

J Immunol Res. 2015;2015:189153. doi: 10.1155/2015/189153. Epub 2015 Aug 17. Review.

43.
44.

Trends in overweight and obesity prevalence in Tuscan schoolchildren (2002-2012).

Lazzeri G, Panatto D, Pammolli A, Azzolini E, Simi R, Meoni V, Giacchi MV, Amicizia D, Gasparini R.

Public Health Nutr. 2015 Dec;18(17):3078-85. doi: 10.1017/S1368980015001676. Epub 2015 May 29.

45.

Age-related differences in the accuracy of web query-based predictions of influenza-like illness.

Domnich A, Panatto D, Signori A, Lai PL, Gasparini R, Amicizia D.

PLoS One. 2015 May 26;10(5):e0127754. doi: 10.1371/journal.pone.0127754. eCollection 2015.

46.

Flucelvax (Optaflu) for seasonal influenza.

Manini I, Domnich A, Amicizia D, Rossi S, Pozzi T, Gasparini R, Panatto D, Montomoli E.

Expert Rev Vaccines. 2015 Jun;14(6):789-804. Review.

PMID:
25968069
48.

Uncontrolled Web-based administration of surveys on factual health-related knowledge: a randomized study of untimed versus timed quizzing.

Domnich A, Panatto D, Signori A, Bragazzi NL, Cristina ML, Amicizia D, Gasparini R.

J Med Internet Res. 2015 Apr 13;17(4):e94. doi: 10.2196/jmir.3734.

49.

Evaluation of the economic burden of Herpes Zoster (HZ) infection.

Panatto D, Bragazzi NL, Rizzitelli E, Bonanni P, Boccalini S, Icardi G, Gasparini R, Amicizia D.

Hum Vaccin Immunother. 2015;11(1):245-62. doi: 10.4161/hv.36160. Review.

50.

Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.

Domnich A, Panatto D, Arbuzova EK, Signori A, Avio U, Gasparini R, Amicizia D.

Hum Vaccin Immunother. 2014;10(10):2819-33. doi: 10.4161/hv.29984. Review.

Supplemental Content

Loading ...
Support Center